SEC Filings Press Releases Related AnalysisIBIO Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced +79.87% iBio, Inc. price and volume Combination chart with 2 data series. Chart represents iBio, Inc. price and volume over 1Y period View as data table, iBio, Inc. price and volu...
iBio develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other…
Sec Filings Annual Quarterly Item Item 2020 2021 2022 2023 2024 5-year trend Sales/Revenue Sales/Revenue 1.64M 2.37M 1.88M - 225K Sales Growth Sales Growth - 44.75% -20.54% - - Cost of Goods Sold (COGS) incl. D&A Cost of Goods Sold (COGS) incl. D&A ...